Disease | The Media Pub News

Immetas Therapeutics announces Series A financing to advance research on inflammation pathways in aging and develop therapeutics for cancer and inflammatory disease

September 23, 2020

Immetas Therapeutics Announces Series A Financing to Advance Research on Inflammation Pathways in Aging and Develop Therapeutics for Cancer and Inflammatory Disease, EAST HANOVER, N.J.–(BUSINESS WIRE)–Immetas Therapeutics today announced it has raised a Series A financing of $11 million to advance research

Business, Healthcare

TYME announces outcome of interim futility review for HopES Sarcoma Phase II study

August 11, 2020

Principal Investigator of the HopES Sarcoma Study Recommended Continuation of the Trial BEDMINSTER, N.J.–(BUSINESS WIRE)–$TYME—Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced today a positive outcome of an interim futility review for the HopES Sarcoma

Local News

Breast cancer survivors tell stories at arts event

June 25, 2017

HAMILTON, N.J. – Twenty-two breast cancer survivors recently participated in the Project WE vs. C event at Grounds for Sculpture in Hamilton, where they told their stories in artistic ways. Project WE vs. C was a two-day event led by Roxey Ballet